CTLA4 and neoplasm: Bacteroides was reported to enhance the anti-CTLA-4 therapy’s efficiency and restore the its effects after an administration of antibiotics through a proposed mechanism involving the activation of the IL-12-dependent Th1 cells with cross-reactivity to tumor and bacterial antigens.